Pinnacle Associates’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Sell
103,140
-1,245
-1% -$14.7K 0.01% 477
2026
Q1
$981K Buy
104,385
+15,901
+18% +$142K 0.01% 522
2025
Q4
$717K Buy
+88,484
New +$967K 0.01% 586
2025
Q1
Sell
-132,580
Closed -$2.41M 831
2024
Q4
$2.41M Sell
132,580
-209,735
-61% -$2.82M 0.03% 348
2024
Q3
$7.75M Buy
342,315
+44,496
+15% +$656K 0.13% 183
2024
Q2
$4.12M Sell
297,819
-35,924
-11% -$569K 0.06% 264
2024
Q1
$6.25M Sell
333,743
-8,572
-3% -$171K 0.1% 217
2023
Q4
$7.75M Sell
342,315
-384
-0.1% -$8.33K 0.13% 186
2023
Q3
$8.5M Buy
342,699
+21,818
+7% +$549K 0.16% 159
2023
Q2
$9.01M Buy
+320,881
New +$7.97M 0.16% 158

Other funds holding CCRN

Pinnacle Associates's CCRN Position: Q2 2026 in Review

Pinnacle Associates reduced its Cross Country Healthcare (CCRN) stake by 1.2% in Q2 2026, selling an estimated $14.7K and leaving 103,140 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #477.

Pinnacle Associates first reported a position in CCRN in Q2 2023 and has held it in 10 quarters since. The position peaked at $9.01M in Q2 2023. 151 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • Pinnacle Associates held 103,140 shares of Cross Country Healthcare worth $1.36M as of Q2 2026.
  • Pinnacle Associates sold 1,245 Cross Country Healthcare shares in Q2 2026, an estimated $14.7K.
  • Cross Country Healthcare made up 0.01% of Pinnacle Associates's portfolio in Q2 2026, its #477 holding.
  • Pinnacle Associates first reported a position in Cross Country Healthcare in Q2 2023 and has held it in 10 quarters since.
  • Pinnacle Associates's Cross Country Healthcare position peaked at $9.01M in Q2 2023.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.